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PubMed Central Deposit and Author Rights 
Agreements between 12 Publishers and the Authors Subject to the NIH Public Access Policy
Ben Grillot1 
Authors and publishers have long negotiated the ownership of copyright in scholarly works. However, with the 
rise of electronic publishing and a growing trend towards open and public access models, traditional author-
publisher agreements are changing. One of many forces bringing about this change is the National Institutes 
of Health’s (NIH) recently revised Public Access Policy, requiring authors of NIH-funded articles to submit 
their works to PubMed Central. As a result of this policy, authors of funded works are looking closely at their 
publication agreements and scientific, technical, and medical journal publishers are re-examining their author 
agreements to accommodate the author’s needs. This paper, in an effort to help authors make informed choices 
about their rights, compares and contrasts how the agreements of 12 publishers permit authors to meet the 
requirements of the NIH Public Access Policy and share their works while they are under embargo.
I. Background 
PubMed Central (PMC) is a free online research archive of peer-reviewed journal articles on biomedicine and 
the life-sciences administered by NIH.  As a trusted repository of valuable scientific research, developed and 
managed by the National Library of Medicine, PMC acts to “ensure the durability and utility” of scientific 
research “as technology changes over time.”2
At the instruction of the US House of Representatives, on February 3, 2005, NIH announced a policy request-
ing the submission to PMC of scholarly works derived, in whole or in part, from research conducted with funds 
from NIH grants.3 Authors were asked to provide the final electronic version of the manuscript as accepted 
by the publisher, including any edits made during the peer-review process. This policy became effective on 
May 2, 2005. In February 2006, as requested by Congress, NIH studied submission rates and determined that 
because compliance with this request was optional, less than four percent of NIH-funded researchers were 
depositing their works into PMC.4 
Based on this progress report, Congress enacted a provision as part of the Consolidated Appropriations Act 
requiring NIH to make this policy mandatory.5 On January 11, 2008, the NIH released a revised policy mak-
ing submission of articles to PMC mandatory. This policy, which became effective on April 7, 2008, requires 
that authors:
funded by the NIH submit or have submitted for them to the National Library of Medicine’s 
PubMed Central an electronic version of their final, peer-reviewed manuscripts upon acceptance 
for publication, to be made publicly available no later than 12 months after the official date of 
publication.6 
1 Ben Grillot, MLS (Maryland 2002), is a second-year student at The George Washington University Law School and 
a summer intern at the Association of Research Libraries. 
2 See “PMC Overview.” http://www.pubmedcentral.nih.gov/about/intro.html
3 See generally Michael W. Carroll, “Complying with the National Institutes of Health Public Access Policy: 
Copyright Considerations and Options.” SPARC / Science Commons / ARL white paper, February 2008. http://
www.arl.org/sparc/advocacy/nih/copyright.shtml
4  “NIH Progress Report to Congress,” February 2006.
5  See Consolidated Appropriations Act, 2008, Pub. L. No. 110-161, Div. G, Tit. II, §218.
6  Ibid. See also “Revised Policy on Enhancing Public Access to Archived Publications Resulting from NIH-Funded 
Research,” NOT-OD-08-033. http://grants.nih.gov/grants/guide/notice-files/NOT-OD-08-033.html
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Prior to this revised policy, some publishers of scientific, technological, and medical research were using 
publication agreements that did not permit authors to retain the rights they needed to submit their works to a 
funder-designated repository. Many publishers have subsequently reviewed and are revising the agreements 
they sign with authors in light of the NIH’s revised policy. This paper compares the terms of these revised 
agreements, examining their support of authors’ needs to comply with NIH policy. 
A complete list of the publishers compared in this paper, along with the author agreements, policy state-
ments, and other relevant documents examined, is provided in the Appendix. All documents examined were 
current as of August 8, 2008, but due to publishers’ evolving approaches to both electronic publishing and the 
NIH policy, these policies are likely to change.7 Further, this sample of publishers is not meant to be compre-
hensive, instead the publishers were chosen because they are illustrative of the range of approaches taken in 
response to the NIH policy. However, those selected do provide a general cross sample of publishers from a 
variety of disciplines that receive NIH funding.
 
II. Analysis of the Agreements
This analysis of author agreements is not exhaustive, instead focusing primarily on those terms affecting an 
author’s ability to comply with the current NIH Public Access Policy. These publication agreements differ from 
each other in three primary ways: the terms of the deposit, the length of the embargo period, and the rights 
retained by the author—both generally and during the embargo period. Three tables below summarize the 
terms of the agreements; some additional analysis is offered to enrich this basic data.
Complying with the Policy
Table 1. Terms of the Deposit in PubMed Central
Agreement Language
In this sample, most publisher agreements explicitly address, and permit, deposit into PMC—either in the 
agreement itself, or, in a few cases, in statements on their Web sites. Further, even when deposit into PMC is 
not mentioned, the agreements generally include language sufficiently broad to cover such use of the work. 
However, reliance on statements posted on Web sites as opposed to language contained in a written publica-
tion agreement is problematic. Illustrating this ambiguity, Taylor & Francis’ (T&F) publicly posted document, 
“Taylor and Francis’s position on Copyright and Author Rights,”8 does not clearly address deposit into PMC.  
In the absence of unambiguous language from the publisher addressing deposit into PMC, authors should 
consider the use of author addenda to supplement the publisher’s agreements and clearly reserve the necessary 
rights to comply with the NIH policy.9 
The Mechanics of the Deposit
Under the NIH policy, it is the author’s responsibility to ensure that a funded work is deposited in PMC, 
but NIH works with publishers who wish to offer either upload or deposit services on behalf of authors. In this 
sample, several journal publishers (e.g., American Association for the Advancement of Science) simply allow 
7   For example, an August 13 press release announced that T&F will upload the author’s accepted version to PMC.  
8 Taylor and Francis, “Taylor and Francis’s position on Copyright and Author Rights.”  
http://www.tandf.co.uk/journals/authorrights.pdf
9 For a broad overview of author addenda see “Authors and Their Rights.” http://www.arl.org/pp/ppcopyright/
author-rights-resources.shtml See also Peter B. Hirtle, “Author Addenda: An Examination of Five Alternatives,” 
D-Lib Magazine 12, no. 11 (November 2006) http://dlib.org/dlib/november06/hirtle/11hirtle.html
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authors to make the deposit as required by NIH. A few (e.g., Elsevier) upload the accepted version and set the 
embargo period, though the author must review and approve that version to complete the deposit process. Still 
others (e.g., Oxford University Press) deposit the publisher’s version on the author’s behalf. 
In some cases, the publisher offers the author an option of full deposit and immediate public availability 
in conjunction with a fee-based immediate-access service. For example, the American Chemical Society (ACS) 
provides a fee-based immediate-access model independent of the NIH deposit requirements. However, fol-
lowing the enactment of NIH’s policy, ACS linked an NIH deposit service to this option. Under this model, 
the only way the publisher will deposit its version into PMC is for the author to pay for immediate access. If 
the author elects to publish under ACS’s traditional program, responsibility for submitting the work remains 
with the author and only the author’s version as accepted may be used. 
The ACS describes these options in its “NIH Policy Addendum.” First, if authors wish “to forgo the NIH’s 
manuscript submission and proofreading tasks,” they can choose ACS’s fee-based AuthorChoice program 
under which “ACS deposits the final published article [to PMC] for immediate open availability,”10 as well as 
makes the article immediately available on the ACS Web site. If the author declines to pay for immediate access 
publication, however, the addendum states that “the author will be responsible for submitting all necessary 
electronic files… [and] will be responsible for proofreading and checking text and other converted files as may 
be required.”11 Further, the agreement states that “ACS accepts no liability for any errors or omissions” in the 
version supplied by the author.12
While it is helpful for authors to have access to immediate availability of their work, the way the deposit 
service is linked to the AuthorChoice program could confuse authors, while the intimidating disclaimer of 
publisher liability might leave them with the mistaken impression that they are assuming a significant risk if 
they fail to pay for immediate access to ensure complete fulfillment of their NIH deposit obligation. 
Publishers have also considered the use of upload fees in conjunction with the NIH Policy.  This fee, un-
like an immediate access fee, does not make the work publicly available immediately, but instead is a cost the 
author must pay for the publisher to upload the work.  In July 2008, the APA announced that it was going to 
begin charging a upload fee of $2,500 for all articles that required submission to PMC. This policy was quickly 
retracted and according to its Web site is “currently being re-examined and will not be implemented at this 
time” leaving the exact duration of the embargo period, while at most 12 months, unclear at present.13  
Table 2. Embargo Periods 
The NIH Public Access Policy permits embargoes on deposited articles for up to a year (12 months) follow-
ing publication. While the length of the embargo period varies by publisher, most journals require authors to 
select an embargo period granting the publisher a period of exclusivity following first publication of the article. 
For example, the American Physical Society, a publisher of physics research, has no embargo period
based on long experience with e-print servers prevalent within the physics community. In contrast, most other 
publishers have periods ranging from 6 to 12 months before they allow the work to be made publicly avail-
able. A publisher that deposits on behalf of an author has the greatest opportunity to ensure that its embargo 
period is correctly established for the work. However, even if authors choose or are required to deposit their 
10 “American Chemical Society Copyright Status Form, NIH Policy Addendum” (Revised April 2008). http://pubs.
acs.org/copyright/nih/nih_addendum.pdf 
11 Ibid.
12 Ibid.
13  “Document Deposit Procedures for APA Journals,” American Psychological Association. http://www.apa.org/
journals/authors/pubmed-deposit.html
Agreements between 12 Publishers and the Authors Subject to the NIH Public Access Policy                               5
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works themselves, the NIH deposit process enables them to honor the embargo period specified in the pub-
lisher agreement.
As was discussed in conjunction with publisher deposit services, some publishers offer authors an immedi-
ate access model through a separate mechanism that eliminates the embargo period in exchange for a one-time 
payment. Among the publishers in this sample, the fee for this service ranges from $850 for immediate access 
from the Proceedings of the National Academy of Sciences (PNAS) for an author whose institution has a PNAS 
site license, to $3,100 for Taylor & Francis for any author. With these two publishers, if an author elects to pay, 
the publisher will immediately deposit the publisher’s version into PMC on behalf of the author, as well as 
make it publicly available on the publisher’s Web site and electronic databases, thus providing authors with a 
double advantage by enhancing distribution of their work and simplifying their deposit process. 
Again, ambiguity in author agreements can make it difficult for authors to understand their options and 
the benefits each offers. Notably, the American Psychological Association’s (APA) agreement does not indicate 
when the article will be deposited to PMC, instead stating only that the APA will submit the manuscript to NIH 
“in a manner consistent with federal law.”14 Thus, the time of deposit as well as the duration of the embargo 
period, and an author’s rights during this period, are unclear. 
Further Complications 
Table 3. Author’s Sharing Rights during Embargo
To comply with the NIH Public Access Policy, authors need to retain sufficient rights in their articles to al-
low them to be deposited in PMC and made publicly accessible within 12 months of publication. In addition to 
these deposit requirements, authors should also consider what rights they retain during any embargo period 
when access to the work will be controled by the publisher. Despite the NIH policy, most publishers consid-
ered here still require authors to give full copyright in the articles to the publisher. In exchange, the publishers 
may grant back to the author non-exclusive licenses to make certain future uses of the work. In this situation, 
NIH-funded authors have to check carefully to be sure that they understand how they can share their works 
before they become publicly accessable in PMC. 
Alternative models allowing authors to retain a broader set of rights are acceptable to some publishers. The 
Model Publication Agreement developed by BioOne in March 2008 responds to the growing movement toward 
funder-mandated public access by allowing the author to retain the copyright in the work while granting the 
publisher a license for publication. This license is exclusive for a period of time and then becomes non-exclusive, 
opening up the options for the author to self-archive or otherwise distribute the article. 
While authors cannot assume that publisher agreements will automatically allow them to retain deposit 
rights, in the agreements examined here publishers generally allow authors sufficient rights to meet their ob-
ligations. However, the rights granted to authors during the embargo period do vary. At the more restrictive 
end of the spectrum, Mary Ann Liebert, Inc.’s  (MAL) Transfer of Copyright form requires an author to assign 
copyright to MAL and does not grant back to the author any rights or provide any licenses to use the material, 
requiring the author to request permission for each use. Slightly less restrictively, the American Chemical 
Society permits the posting of an abstract to the author’s personal Web site and limits to 50 the number of 
copies of the final article that can be distributed, presented orally, or transmitted to colleagues. Additionally, 
the ACS only permits transmission on an employer’s internal, secure network if it is a “work for hire.” Taking 
a more liberal approach, PNAS permits authors to post the publisher’s version on their own Web sites during 
the embargo and does not limit the quantity or format for distribution to students or use on a secure intranet 
site.
14  “APA Publications Rights Form,” American Psychological Association. http://www.apa.org/journals/authors/
publication_rights_form.pdf
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